Penpulimab combined with anlotinib in patients with R/M HNSCC after failure of platinum-based chemotherapy: a single-arm, multicenter, phase Ⅱ study
- Resource Type
- Article
- Source
- In
ESMO Open December 2023 8(6) - Subject
ENT Cancers - Language
- ISSN
- 2059-7029